Intraoperative Radiotherapy (IORT) Devices Market Report 2026

Intraoperative Radiotherapy (IORT) Devices Market Report 2026 Market Overview

• Intraoperative Radiotherapy (IORT) Devices Market Report 2026 market size has reached to $0.46 billion in 2025 • Expected to grow to $0.7 billion in 2030 at a compound annual growth rate (CAGR) of 8.6% • Growth Driver: Surge In Breast Cancer Incidence Fueling The Growth Of The Market Due To Increasing Demand For Targeted Radiation Treatment • Market Trend: Innovations in Robotic-Assisted Intraoperative Radiotherapy (IORT) Technology Enhance Precision and Workflow Efficiency • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Intraoperative Radiotherapy (IORT) Devices Market?

Intraoperative radiotherapy devices are specialized medical systems that deliver a precise dose of radiation directly to the treatment area during surgery, immediately after diseased tissue is removed. This approach helps target remaining cancer cells while minimizing radiation exposure to nearby healthy tissues. Intraoperative radiotherapy devices combine advanced radiation delivery and imaging technologies to provide accurate and efficient treatment in the operating room. The main product types of intraoperative radiotherapy (IORT) devices include mobile intraoperative radiotherapy systems and fixed intraoperative radiotherapy systems. Mobile intraoperative radiotherapy systems refer to portable radiation delivery platforms that can be moved between operating rooms, providing targeted radiation treatment immediately after tumor removal during surgical procedures. These systems utilize technologies such as electron beam intraoperative radiotherapy, low energy X ray intraoperative radiotherapy, high energy X ray intraoperative radiotherapy, and intraoperative brachytherapy. The various applications involved are breast cancer, colorectal cancer, pancreatic cancer, prostate cancer, head and neck cancer, and others, and they are used by several end users such as hospitals, ambulatory surgical centers, cancer research institutes, and specialty oncology clinics.

What Is The Intraoperative Radiotherapy (IORT) Devices Market Growth Forecast?

The intraoperative radiotherapy (IORT) devices market size is expected to see strong growth in the next few years. It will grow to $0.7 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing preference for personalized cancer treatment, rising demand for precision radiation delivery solutions, growing adoption of mobile intraoperative radiotherapy systems, expanding integration of image-guided surgical technologies, increasing investment in advanced oncology treatment facilities. Major trends in the forecast period include increasing adoption of precise radiation delivery systems, growing integration of real-time imaging in surgical procedures, rising demand for single-session cancer treatment approaches, expansion of minimally invasive oncology treatment solutions, growing development of compact and mobile radiotherapy systems.

What Is The Driver Of The Intraoperative Radiotherapy (IORT) Devices Market?

The rising breast cancer incidence is expected to propel the growth of the intraoperative radiotherapy (IORT) devices market going forward. Breast cancer refers to a disease in which abnormal cells develop and grow uncontrollably in the breast tissue, forming malignant tumors that can spread to other parts of the body. The rising incidence of breast cancer is driving demand for timely diagnosis and effective treatment, increasing the adoption of advanced therapies that improve clinical outcomes and support better disease management. The rising incidence of breast cancer is increasing the number of patients requiring breast-conserving surgery, driving demand for intraoperative radiotherapy (IORT) devices that deliver targeted radiation during surgery and reduce the need for multiple postoperative radiotherapy sessions. For instance, in June 2026, according to the Centers for Disease Control and Prevention, a US-based federal agency, the United States recorded 288,494 new cases of female breast cancer in 2023, while 43,402 women died from the disease in 2024. Therefore, a rising breast cancer incidence is driving the growth of the intraoperative radiotherapy (IORT) devices industry.

Key Players In The Global Intraoperative Radiotherapy (IORT) Devices Market

Major companies operating in the intraoperative radiotherapy (iort) devices market report are Carl Zeiss Meditec AG, Elekta AB, Siemens Healthineers AG, Panacea Medical Technologies Pvt. Ltd., Brainlab AG, Ion Beam Applications SA, IntraOp Medical Corporation, S.I.T. Sordina IORT Technologies S.p.A., Xstrahl Ltd, Eckert & Ziegler BEBIG GmbH, RaySearch Laboratories AB, PTW Freiburg GmbH, ORFIT Industries NV, Cablon Medical B.V., Standard Imaging Inc., LAP GmbH Laser Applications, Mirion Technologies Inc., GMV Innovating Solutions SL, CivaTech Oncology Inc., Radiation Products Design Inc.

Global Intraoperative Radiotherapy (IORT) Devices Market Trends and Insights

Major companies operating in the intraoperative radiotherapy (IORT) devices market are focusing on developing advanced robotic-assisted radiation therapy platforms to improve treatment precision, streamline clinical workflows, and enhance connectivity across surgical oncology procedures. Robotic-assisted intraoperative radiotherapy platforms are advanced systems that enable highly accurate radiation delivery during surgery through automated positioning, digital treatment planning, and seamless integration with hospital infrastructure. For instance, in April 2025, Carl Zeiss Meditec AG, a Germany-based medical technology company, received U.S. Food and Drug Administration (FDA) 510(k) clearance for the ZEISS INTRABEAM 700, a next-generation intraoperative radiotherapy platform. The system features robotic-assisted precision, digital-first workflow architecture, integrated Radio Frequency Identification (RFID)-enabled applicator recognition, and advanced treatment planning software, supporting more accurate and efficient intraoperative radiation therapy for neuro-oncology and breast cancer procedures.

What Are Latest Mergers And Acquisitions In The Intraoperative Radiotherapy (IORT) Devices Market?

In October 2023, Elekta AB, a Sweden-based provider of radiation therapy, radiosurgery, and brachytherapy systems and treatment-planning software for cancer and brain disorder care, acquired the Xoft brachytherapy business from iCAD, Inc. for an undisclosed amount. With this acquisition, Elekta aimed to broaden its intraoperative and electronic brachytherapy portfolio and extend access to precision radiation treatment across a wider range of clinical settings by leveraging its global commercial network. iCAD Inc. is a US-based medical technology company that developed the Xoft Axxent Electronic Brachytherapy (eBx) System, an electronic radiation platform widely used for intraoperative radiotherapy (IORT) procedures.

What Defines the Intraoperative Radiotherapy (IORT) Devices Market?

The intraoperative radiotherapy devices market consists of revenues earned by entities by providing services such as remote monitoring services, equipment lifecycle management services, and decommissioning and disposal services. The market value includes the value of related goods sold by the service provider or included within the service offering. The intraoperative radiotherapy devices market also includes sales of laser positioning devices, radiation monitoring badges, and equipment transport trolleys. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Intraoperative Radiotherapy (IORT) Devices Market Report 2026?

The intraoperative radiotherapy (iort) devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the intraoperative radiotherapy (iort) devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.